Concepedia

Purvish Parikh

PP

4

Publications

146

Citations

4

H-Index

2005

Active since

Affiliations

Tata Memorial Hospital(Current)

Jaslok Hospital

Deenanath Mangeshkar Hospital and Research Center

Rajiv Gandhi Cancer Institute and Research Centre

Jehangir Hospital

Purvish Parikh is an author at Tata Memorial Hospital specializing in pharmacotherapy, medicine, and oncology.

Top concepts

Publications per year

2005–2013

4

Publications

4

Pr4 ISEL: A Phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC, in patients with advanced non-small-cell lung cancer (NSCLC) who had received one or two prior chemotherapy regimens

Nicholas Thatcher, Amy Chang, Purvish Parikh et al. · Lung Cancer · 2005 · 69 citations

, , +8

Chronic myeloid leukemia data from India

Shweta Bansal, Kumar Prabhash, Purvish Parikh · Indian Journal of Medical and Paediatric Oncology · 2013 · 41 citations · Full text

, , +12

Clinical Experience with Gefitinib in Indian Patients

Purvish Parikh, Alex Y. Chang, Shona Nag et al. · Journal of Thoracic Oncology · 2008 · 26 citations · Full text

, , +3

Oral talactoferrin extends survival in patients with refractory NSCLC in a randomized, placebo-controlled, phase 2 trial

Purvish Parikh, Y. Wang, Anantbhushan Ranade et al. · Journal of Clinical Oncology · 2007 · 10 citations

, , +14

Rows per page

1–4 of 4